C4 Therapeutics, Inc. · NASDAQ:CCCC
Lynx1 Capital Management LP reported a 7.30% stake in C4 Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Lynx1 Capital Management LP reported a 7.30% stake in C4 Therapeutics, Inc., 7,098,133 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 7.30%
- Shares
- 7,098,133
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lynx1 Capital Management LP | 7.30% | 7,098,133 |
| Weston Nichols | 7.30% | 7,098,133 |
Source
Related
- C4 Therapeutics, Inc.
- Lynx1 Capital Management LP
- C4 Therapeutics, Inc. shareholders
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Grogan Donna Roy · Oct 2, 2026
- Form 4 · Adams Kendra · Sep 21, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026